Anti-G. vaginalis VLY toxin Therapeutic Antibody

  • Check with publisher
  • Published date: November 20, 2017
    • Shirley, New York, United States

This antibody against VLY can inhibit toxin-mediated cytolysis and in particular can be used therapeutically to treat G. vaginalis infections by neutralizing free VLY. http://www.creativebiolabs.net/Anti-G-vaginalis-VLY-toxin-Therapeutic-Antibody-44550.htm

Bella
1 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-Gram-negative bacteria flagellin Therapeutic Antibody (763)

    Anti-Gram-negative bacteria flagellin Therapeutic Antibody (763)

    Biological Sciences Shirley (New York) November 20, 2017 Check with publisher

    This monoclonal antibody has a high affinity, broad spectrum neutralizing reactivity to flagellin from various Gram-negative bacteria including E. coli, Salmonella, Serratia, Proteus, Enterobacter, Citrobacter, Campylobacter and Pseudomonas. It can b...

  • Anti-Gram-negative bacteria flagellin Therapeutic Antibody (741)

    Anti-Gram-negative bacteria flagellin Therapeutic Antibody (741)

    Biological Sciences Shirley (New York) November 20, 2017 Check with publisher

    This monoclonal antibody has a high affinity, broad spectrum neutralizing reactivity to flagellin from various Gram-negative bacteria including E. coli, Salmonella, Serratia, Proteus, Enterobacter, Citrobacter, Campylobacter and Pseudomonas. It can b...

  • Anti-E. coli TolC Therapeutic Antibody

    Anti-E. coli TolC Therapeutic Antibody

    Biological Sciences Shirley (New York) November 20, 2017 Check with publisher

    This antibody against TolC fragment improves the sensitivity of bacteria to antibiotics and can specifically and effectively inhibit the function of medicament resistant outer membrane protein TolC of Escherichia coli so as to solve the problem of ba...